Infectious Diseases
Latest news
256 articles · 20 / page
RSV-Related Hospitalization Linked to Surge in Acute Myocardial Infarction and Stroke Risk
A large-scale study reveals that RSV hospitalization significantly increases the risk of myocardial infarction, stroke, and heart failure exacerbations, with the highest risk occurring within the first week post-admission, emphasizing the c
Precision Immunotherapy in Pneumonia: Presepsin-Guided Anakinra Significantly Reduces Organ Dysfunction and Mortality
The Phase IIa INSPIRE trial demonstrates that early administration of anakinra, guided by the presepsin biomarker, reduces the risk of organ dysfunction by 30% and significantly improves 90-day survival in hospitalized pneumonia patients, m
The Multi-Billion Dollar Toll of Chagas Disease: Why Aging Populations and Chronic Cardiac Care are Driving Economic Burden in Latin America
A comprehensive cost-of-illness analysis from the RAISE study reveals that Chagas disease imposes a massive economic burden on Latin American countries, driven by a shift toward chronic cardiac complications in aging populations, despite de
Dual-Action IgY and Cerium Oxide Nanofibrous Dressings Accelerate Scarless Healing in Infected Wound Models
Researchers have developed a novel P/G@IYCe dressing combining yolk immunoglobulins and cerium oxide nanoparticles. This synergy effectively neutralizes bacterial pathogens and reactive oxygen species, facilitating rapid, high-quality skin
Significant Barriers and Pandemic Setbacks: Why Hepatitis B Birth Dose Coverage Remains Low in The Gambia
A 7-year retrospective analysis in The Gambia reveals that despite early adoption, timely Hepatitis B birth dose coverage remains critically low at 6.4%, severely hindered by weekend births and the COVID-19 pandemic.
Adjunct Dexamethasone in Herpes Simplex Encephalitis: Safe but Fails to Improve Long-Term Verbal Memory in the DexEnceph Trial
The Phase 3 DexEnceph trial found that adjunct dexamethasone is safe in adults with HSV encephalitis but does not significantly improve verbal memory scores at 26 weeks compared to aciclovir monotherapy, suggesting a need for earlier or mor
Preexisting Antiviral Immunity and Allogeneic T-Cell Transfer: Redefining the Therapeutic Landscape of Progressive Multifocal Leukoencephalopathy
Recent studies highlight the critical role of virus-specific T-cells in treating progressive multifocal leukoencephalopathy. Pre-existing T-cells predict superior responses to checkpoint inhibitors, while allogeneic T-cell transfer offers a
Antibiotics vs. Surgery for Uncomplicated Appendicitis: 10-Year APPAC Trial Results Confirm Long-Term Viability
The 10-year follow-up of the APPAC trial demonstrates that antibiotic therapy remains a safe and effective alternative to appendectomy for uncomplicated acute appendicitis, with over 60% of patients successfully avoiding surgery for a decad
High-Dose Influenza Vaccine Offers Superior Protection Against Hospitalization in Older Adults Regardless of Diabetes Status
A secondary analysis of the DANFLU-2 trial demonstrates that high-dose influenza vaccines significantly reduce cardiorespiratory and influenza-related hospitalizations in adults aged 65 and older, with consistent benefits observed in patien
The Changing Landscape of Acute Invasive Fungal Rhinosinusitis: Rising Detection and Declining Mortality
A landmark systematic review of over 48,000 patients reveals that while the proportion of AIFRS in immunocompromised populations is increasing, mortality rates have dropped significantly since 2013 due to diagnostic and therapeutic advancem
AIFRS Mortality Drops as Detection Rates Climb: New Insights into Acute Invasive Fungal Rhinosinusitis
A comprehensive meta-analysis reveals that while the proportion of AIFRS in immunocompromised patients has risen to 16.6% in recent years, mortality has significantly decreased to 28.2% due to improved diagnostic and therapeutic strategies.
Maternal Vaccination and Infant Whole-Cell Pertussis Series Synergize for Superior Mucosal Immunity
A phase 4 trial in The Gambia reveals that maternal Tdap-IPV vaccination provides early mucosal IgG to infants, while the DTwP primary series induces significantly stronger mucosal antibody and T-cell responses than DTaP, despite maternal a
Rethinking Scabies Treatment: Why Permethrin Cream Still Leads Over Oral Ivermectin
A large-scale multicentre clinical trial reveals that 5% permethrin cream is significantly more effective than oral ivermectin for treating scabies in households, providing crucial evidence for public health and clinical practice.
Beyond the Hospital Walls: Can Prospective Audit and Feedback Solve the Discharge Antibiotic Dilemma?
A multicenter stepped-wedge trial reveals that while prospective audit and feedback by stewardship teams improves the quality of discharge antibiotic prescribing, it fails to reduce the overall volume or duration of therapy, highlighting th
AI-Driven Decision Support for Antibiotic Switching: Why Clinicians Value Caution Over Speed
A randomized multimethod study reveals that while AI clinical decision support systems for antibiotic switching are well-received, their primary influence is reinforcing conservative prescribing. The study underscores that usability and cli
Twice-Daily Bictegravir-Based Therapy Proves Effective and Safe During Rifampicin-Based Tuberculosis Treatment: Insights from the INSIGHT Trial
The Phase 2b INSIGHT study demonstrates that twice-daily bictegravir-emtricitabine-tenofovir alafenamide (B/F/TAF) is highly effective and safe for treating HIV in patients receiving rifampicin-based tuberculosis therapy, achieving over 94
Two-Dose HeV-sG-V Regimen Demonstrates Robust Neutralizing Antibody Response Against Nipah Virus in Phase 1 Trial
A Phase 1 trial confirms that the HeV-sG-V vaccine is safe and, when administered in a two-dose 100 μg regimen, induces high levels of neutralizing antibodies against both Bangladesh and Malaysia strains of the Nipah virus.
A Breath of Protection: How a New Nasal Vaccine Could Stop Whooping Cough in its Tracks
A groundbreaking clinical trial reveals that a novel nasal vaccine, BPZE1, can prevent Bordetella pertussis colonization, offering a potential solution to the transmission gaps in current whooping cough immunization programs.
Dual-Purpose Public Health: Ivermectin Mass Drug Administration Reduces Malaria Incidence and Scabies Prevalence
Large-scale trials in Kenya and Mozambique demonstrate that ivermectin mass drug administration significantly reduces malaria incidence by 26% and lowers community scabies prevalence, providing both direct protection and indirect herd-like
Delpazolid Emerges as a Safer Oxazolidinone Alternative for Tuberculosis: Results from the PanACEA-DECODE-01 Trial
The Phase 2b PanACEA-DECODE-01 trial identifies delpazolid 1200 mg once daily as an effective and safer oxazolidinone alternative to linezolid, demonstrating a 38% faster mycobacterial load decline when added to a bedaquiline, delamanid, an
Browse by specialty
Open language-specific specialty feeds and department pages.